The UAE Ministry of Health and Prevention (MoHAP) has signed a Memorandum of Cooperation (MoC) with Mediclinic Middle East to strengthen mutual relations between the Ministry’s National Centre for Health Research (NCHR) and the group in exploring avenues of developing and enhancing health research.
Under the agreement, both entities will improve their coordination and cooperation in organizing scientific conferences, training programs, and workshops related to health research and priority clinical trials in the country. They will also cooperate to facilitate the exchange of expertise and capabilities.
The partnership deal was signed at the ministry’s headquarters by Mr. Khalil Ibrahim Qayed, Director of NCHR, and Mr. David Hadley, CEO of Mediclinic Middle East, in the presence of Dr. Mohammed Salim Al Olama, Under-Secretary of MoHAP.
Dr. Mohammed Salim Al Olama Under-Secretary MoHAP
“The ministry’s keenness to involve the private sector in the development of integrated plans, programs, and initiatives to provide an innovative research environment that fosters knowledge and innovation, helps develop and support scientific research, while also instilling a healthy research culture in accordance with the highest international practices. These are factors that would help us strengthen the country’s competitive capacities locally and internationally, solidify the UAE’s position as an ideal destination for scientific and medical research, and improve its reputation as a vibrant nation in the global health scene.”
Mr. Hadley said that “The operation of Mediclinic Middle East is underpinned by our company philosophy, ‘the science of care’. It is our intention that all our doctors be armed with practical and exacting knowledge, which enables them to treat their patients with the highest levels of evidence-based medicine.”
